We are live on ! Find out more
Candriam SCA

Candriam SCA Portfolio holdings

AUM $22.5B Turnover 10.3%
1-Year Est. Return 50.38%
 

Candriam is a Luxembourg asset manager with sustainable investing at its core, run as a subsidiary of New York Life Investments, with Belgian bank Belfius holding a minority stake. It was previously Dexia Asset Management and took the Candriam name in 2014, short for "Conviction AND Responsibility In Asset Management", after New York Life's asset management arm acquired it. Its funds span bonds, stocks, absolute return strategies and asset allocation, and its portfolios exclude controversial weapons, thermal coal and tobacco. In 2021 it bought a majority stake in the European real estate manager Tristan Capital Partners.

This Fund
S&P 500
This Quarter Est. Return
+6.07%
1 Year Est. Return
+50.38%
3 Year Est. Return
+175.97%
5 Year Est. Return
+212.01%
10 Year Est. Return
+804.31%
AUM
$22.5B
AUM Growth
+$301M
Cap. Flow
-$416M
Cap. Flow %
-1.85%
Top 10 Hldgs %
34.05%
Holding
699
New
21
Increased
252
Reduced
270
Closed
51
Avg Time Held
6.2 years
Top 10 Avg Time Held
3.9 years
Top 20 Avg Time Held
3.4 years

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$98.2M
2
META icon
Meta Platforms (Facebook)
META
+$82.9M
3
NOW icon
ServiceNow
NOW
+$70.4M
4
INTC icon
Intel
INTC
+$58.4M
5
CRM icon
Salesforce
CRM
+$54.9M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$102M
2
PANW icon
Palo Alto Networks
PANW
+$102M
3
ABBV icon
AbbVie
ABBV
+$68.9M
4
AMZN icon
Amazon
AMZN
+$57M
5
NVDA icon
NVIDIA
NVDA
+$54.1M

Sector Composition

Rank Sector Weight
1 Technology 41.06%
2 Healthcare 24.01%
3 Financials 9.02%
4 Communication Services 7.08%
5 Consumer Discretionary 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TROW icon
401
T. Rowe Price
TROW
$21.5B
$4.2M 0.02%
40,249
-384
-0.9% -$43K
2014 Q4
47 quarters
HUBB icon
402
Hubbell
HUBB
$21.3B
$4.17M 0.02%
9,150
+696
+8% +$331K
2022 Q4
15 quarters
GIS icon
403
General Mills
GIS
$19.1B
$4.13M 0.02%
128,009
-527
-0.4% -$19.7K
2014 Q4
47 quarters
BMI icon
404
Badger Meter
BMI
$4.41B
$4.1M 0.02%
33,101
-7,259
-18% -$978K
2021 Q3
20 quarters
F icon
405
Ford
F
$44.6B
$4.06M 0.02%
335,442
+35,898
+12% +$498K
2014 Q4
47 quarters
HUM icon
406
Humana
HUM
$46.8B
$3.98M 0.02%
10,399
-117
-1% -$45.5K
2014 Q4
47 quarters
ADM icon
407
Archer Daniels Midland
ADM
$31.9B
$3.91M 0.02%
49,046
+19,129
+64% +$1.57M
2016 Q1
42 quarters
EOG icon
408
EOG Resources
EOG
$77B
$3.89M 0.02%
28,146
-251
-0.9% -$35.8K
2014 Q4
47 quarters
NTAP icon
409
NetApp
NTAP
$31B
$3.84M 0.02%
18,212
-208
-1% -$38.4K
2016 Q2
41 quarters
OXY icon
410
Occidental Petroleum
OXY
$53.9B
$3.82M 0.02%
68,809
+11,187
+19% +$639K
2014 Q4
47 quarters
AZO icon
411
AutoZone
AZO
$52.4B
$3.79M 0.02%
1,334
+280
+27% +$837K
2016 Q1
42 quarters
KHC icon
412
Kraft Heinz
KHC
$30.1B
$3.77M 0.02%
165,474
-14,937
-8% -$376K
2015 Q3
44 quarters
AFL icon
413
Aflac
AFL
$61.5B
$3.74M 0.02%
33,380
-936
-3% -$112K
2016 Q1
42 quarters
LH icon
414
Labcorp
LH
$29.8B
$3.7M 0.02%
11,950
-96
-0.8% -$29.8K
2014 Q4
47 quarters
LULU icon
415
lululemon athletica
LULU
$11.9B
$3.69M 0.02%
38,177
-26,689
-41% -$3.03M
2017 Q2
37 quarters
IBKR icon
416
Interactive Brokers
IBKR
$32.3B
$3.67M 0.02%
42,750
+1,271
+3% +$116K
2025 Q1
6 quarters
EG icon
417
Everest Group
EG
$15.6B
$3.66M 0.02%
9,996
– –
2021 Q2
21 quarters
RKLB icon
418
Rocket Lab
RKLB
$30.6B
$3.61M 0.02%
51,675
+16,518
+47% +$1.19M
2025 Q3
4 quarters
CARR icon
419
Carrier Global
CARR
$40.9B
$3.6M 0.02%
65,370
-37,135
-36% -$2.3M
2020 Q2
25 quarters
CRS icon
420
Carpenter Technology
CRS
$12.6B
$3.58M 0.02%
+9,172
New +$4.66M
2026 Q3
0 quarters
RMD icon
421
ResMed
RMD
$33.1B
$3.47M 0.02%
15,628
+777
+5% +$169K
2019 Q2
29 quarters
CBOE icon
422
Cboe Global Markets
CBOE
$37.3B
$3.44M 0.02%
12,460
-643
-5% -$182K
2018 Q4
31 quarters
JBHT icon
423
JB Hunt Transport Services
JBHT
$20.4B
$3.44M 0.02%
15,303
+94
+0.6% +$25.2K
2023 Q1
14 quarters
ORA icon
424
Ormat Technologies
ORA
$5.16B
$3.34M 0.01%
36,407
-22,510
-38% -$2.32M
2024 Q4
7 quarters
STM icon
425
STMicroelectronics
STM
$34.9B
$3.31M 0.01%
61,863
-28,947
-32% -$1.6M
2025 Q2
5 quarters

Similar funds

Candriam SCA's Q3 2026 Portfolio in Review

As of Q3 2026, Candriam SCA held 699 positions worth $22.5B, up 1.4% from $22.2B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Candriam SCA's Q3 2026 filing shows 21 new, 252 increased, 270 reduced and 51 closed positions. Its largest new stake was Zenas BioPharma: 654,833 shares worth $17.7M. The largest sale was Alphabet (Google) Class A, an estimated $102M.

By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 38% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2026 buy was Zenas BioPharma: 654,833 shares worth $17.7M.
  • Candriam SCA added most to Abbott in Q3 2026, an estimated $98.2M increase.
  • Candriam SCA's biggest Q3 2026 reduction was Alphabet (Google) Class A, cutting an estimated $102M.
  • Candriam SCA fully exited StoneX in Q3 2026, selling an estimated $46.1M.
  • Candriam SCA's ten largest holdings make up 34% of its $22.5B portfolio in Q3 2026.
  • Candriam SCA opened 21 new positions and closed 51 in Q3 2026.
  • Candriam SCA's portfolio value rose 1.4% quarter-over-quarter to $22.5B.

Based on Candriam SCA's 13F filing for Q3 2026, filed 3 Nov 2026.